Gluk5 (Kar5) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Glutamate ionotropic kainate receptor subunit 5 (GluK5), also known as KAR5 or GRIK5, is a high-affinity kainate receptor subunit that forms functional ion channels when combined with other subunits (primarily GRIK4 or GRIK3). These receptors are widely distributed throughout the central nervous system, particularly in the hippocampus, cerebral cortex, and limbic structures. GluK5-containing receptors play crucial roles in synaptic transmission, network oscillations, and higher cognitive functions including memory formation and consolidation. [@kainate2020]
Gluk5 (Kar5) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Glutamate ionotropic kainate receptor subunit 5 (GluK5), also known as KAR5 or GRIK5, is a high-affinity kainate receptor subunit that forms functional ion channels when combined with other subunits (primarily GRIK4 or GRIK3). These receptors are widely distributed throughout the central nervous system, particularly in the hippocampus, cerebral cortex, and limbic structures. GluK5-containing receptors play crucial roles in synaptic transmission, network oscillations, and higher cognitive functions including memory formation and consolidation. [@kainate2020]
Molecular Biology and Receptor Physiology
Structure and Pharmacology
The GluK5 subunit (encoded by the GRIK5 gene on chromosome 19q13.3) belongs to the kainate receptor family within the ionotropic glutamate receptor superfamily. Unlike AMPA and NMDA receptors, kainate receptors including GluK5 have distinct pharmacological profiles: [@altered2018]
High-affinity glutamate binding: GluK5-containing receptors exhibit nanomolar affinity for glutamate, making them sensitive to low synaptic concentrations
Kainate as agonist: Kainic acid potently activates these receptors (EC50 ~100 nM)
ATPA as selective agonist: (2S,4R)-4-Phosphonomethyl-2-pyrrolidineacetic acid (ATPA) is a selective GluK5 agonist
LY382884 and LY466365: Selective antagonists that block GluK5-containing receptors
The receptor forms as a tetramer, typically as GluK5/GRIK4 heteromers in vivo, creating channels with distinct kinetic properties including: [@gluk2021]
Slow deactivation kinetics (~200-500 ms)
Moderate conductance (10-15 pS)
Voltage-independent magnesium block
Prominent desensitization in the presence of glutamate
Regional Distribution
In the mammalian brain: [@atpa2017]
Physiology and Function
Synaptic Transmission
GluK5-containing kainate receptors are located at both pre- and postsynaptic sites:
GluK5 receptors critically contribute to brain oscillations:
Theta oscillations (4-8 Hz): GluK5 in hippocampus is essential for theta rhythm generation and maintenance, which is crucial for spatial memory and navigation
Patch-clamp recordings from GluK5-expressing neurons
Measurement of kainate-evoked currents
Analysis of synaptic currents
Molecular Biology
GRIK5 knockout and transgenic mice
siRNA knockdown in vitro
CRISPR-based gene editing
Imaging
GluK5-specific antibodies for immunohistochemistry
Radioligand binding (3H-ATPA)
PET tracers under development
Background
The study of Gluk5 (Kar5) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.